483
Andrew C. Siesennop, MDAndrew C. Siesennop, MD – FDA 483, Aug 4, 2023
Record Details
An FDA inspection of Andrew C. Siesennop, MD in Boston, MA, revealed a significant issue with the conduct of an investigational study. The firm failed to follow its investigational plan, resulting in three subjects being incorrectly dosed with the study drug. This indicates a deviation from proper clinical trial procedures.
View Company Profile
ID · 507aefc9-8f3c-4b92-88d6-1fc83d8052e3
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.